Blackstone, Legal & General Sign Up to $20 Billion Private-Credit Partnership
Under the deal, the annuities business of the British insurer and pension provider will get access to mostly U.S. investment-grade assets via Blackstone's lending platform for private markets. L&G will invest up to 10% of the division's new business flows into it, they said Thursday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Carry Wealth Holdings Leads The Charge In Asian Penny Stocks
Amidst a backdrop of global economic uncertainty, Asian markets have been navigating the complexities of trade tensions and fluctuating economic data. In such times, investors often look beyond established giants to explore opportunities in smaller or newer companies, sometimes referred to as penny stocks. Although the term may seem outdated, these stocks can still present valuable opportunities when backed by strong financials and growth potential. This article explores three Asian penny stocks that stand out for their balance sheet resilience and potential for significant returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.10 THB4.05B ★★★★★☆ Lever Style (SEHK:1346) HK$1.48 HK$933.81M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.39 HK$1.99B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.515 SGD208.72M ★★★★★☆ T.A.C. Consumer (SET:TACC) THB4.66 THB2.8B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.73 SGD695.97M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.53 SGD9.96B ★★★★★☆ Livestock Improvement (NZSE:LIC) NZ$1.00 NZ$142.34M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.70 THB9.5B ★★★★★★ BRC Asia (SGX:BEC) SGD3.57 SGD979.43M ★★★★★★ Click here to see the full list of 987 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Carry Wealth Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: Carry Wealth Holdings Limited is an investment holding company that manufactures, trades, and markets garment products for various brands across the United States, Mainland China, Europe, Hong Kong, and internationally with a market cap of HK$431.93 million. Operations: The company's revenue is primarily derived from its Garment Manufacturing and Trading segment, which generated HK$664.69 million. Market Cap: HK$431.93M Carry Wealth Holdings Limited, with a market cap of HK$431.93 million, primarily generates revenue from its Garment Manufacturing and Trading segment. Despite being unprofitable, the company is debt-free and maintains a strong cash runway exceeding three years based on current free cash flow. Recent board changes introduced experienced financial professionals, potentially strengthening oversight. However, high share price volatility persists alongside negative return on equity at -22.85%. While short-term assets comfortably cover liabilities, both management and board tenures are relatively short, indicating an evolving leadership team as the company navigates its challenges in the competitive garment industry. Jump into the full analysis health report here for a deeper understanding of Carry Wealth Holdings. Review our historical performance report to gain insights into Carry Wealth Holdings' track record. Qinghai Spring Medicinal Resources Technology Simply Wall St Financial Health Rating: ★★★★★★ Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥25.01 billion. Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported specific revenue segments. Market Cap: CN¥2.5B Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥25.01 billion, operates without significant revenue streams, indicating it may be pre-revenue. The company is debt-free and possesses a robust cash runway exceeding three years based on current free cash flow. Despite its unprofitability and negative return on equity at -15.54%, the management team and board are experienced, averaging tenures of 10.4 and 5.7 years respectively. Short-term assets significantly exceed liabilities, providing financial stability amidst challenges in achieving profitability as earnings have declined by 8.5% annually over the past five years. Navigate through the intricacies of Qinghai Spring Medicinal Resources Technology with our comprehensive balance sheet health report here. Learn about Qinghai Spring Medicinal Resources Technology's historical performance here. Zhejiang CONBA PharmaceuticalLtd Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.53 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥6.38 billion. Market Cap: CN¥11.53B Zhejiang CONBA Pharmaceutical Co., Ltd. has shown financial resilience with a significant reduction in its debt to equity ratio from 63.8% to 3.9% over five years, and its short-term assets of CN¥4.5 billion comfortably cover both short and long-term liabilities. Despite a low return on equity at 8.7%, the company has maintained stable earnings growth, surpassing industry averages with a recent annual increase of 13.8%. However, its dividend track record remains unstable, and the board's average tenure of 1.6 years suggests limited experience in navigating market complexities effectively. Click here to discover the nuances of Zhejiang CONBA PharmaceuticalLtd with our detailed analytical financial health report. Assess Zhejiang CONBA PharmaceuticalLtd's previous results with our detailed historical performance reports. Make It Happen Explore the 987 names from our Asian Penny Stocks screener here. Curious About Other Options? Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:643 SHSE:600381 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
7 minutes ago
- Yahoo
Liverpool players agrees new deal
One Liverpool player has agreed a brand new role and contract with the club. We've seen a lot of changes at Anfield this summer. Richard Hughes and Arne Slot are working on establishing a new era and dynasty. 🔴 Shop the LFC 2025/26 adidas home range Shop the LFC Store 🚨2025/26 LFC x adidas range🚨 LFC x adidas Shop the away range TODAY LFC x adidas Shop the home range today! LFC x adidas Shop the goalkeeper range today LFC x adidas Shop the new adidas range today! This is a new dynasty that is tailored more in their image, and a gradual stepping away from the Jurgen Klopp era, which was undeniably successful at Liverpool. Nonetheless, new ideas and fresh faces are always welcome in order to inspire an evolution and that is what Hughes will be wanting to achieve. These changes do not just involve players coming and going. We have seen a number of staff changes as well with the likes of Xavi Valero and Giovanni van Bronckhorst appointed in prominent positions in Arne Slot's backroom. 🔴 Shop the LFC 2025/26 adidas away range Not to mention it's not just the first team making changes but the academy as well. Notably Barry Lewtas, the club's U21 coach and Marc Bridge-Wilkinson, the club's U18 coach have both left the club. They have been replaced by Rob Page at U21 level, and Simon Wiles at U18 level. The duo come with impressive resumes. Page achieved a lot of success with Wales at senior level and he was very effective at promoting young Welsh talent into the national team. Wiles has worked at Salford City's first team and was poached from Manchester United in what is regarded as a major coup by the Reds. He's not the only new addition to the club's academy either.
Bloomberg
8 minutes ago
- Bloomberg
OPEC+ Confirms Bumper Oil Output Boost
Good morning. OPEC+ agrees to another output increase. Swiss markets get a chance to react to Donald Trump's tariffs. And our luxury reporter shares countryside escapes close to London. Listen to the day's top stories. OPEC+ agreed to another major output increase, stoking concerns about global oversupply just as the US-led trade war may be exacting a toll on economic growth and energy consumption. Here's our explainer about how OPEC+ and tariffs are driving down prices of the commodity.
